The stock of NanoString Technologies Inc (NASDAQ:NSTG) hit a new 52-week high and has $58.32 target or 188.00% above today’s $20.25 share price. The 5 months bullish chart indicates low risk for the $409.41 million company. The 1-year high was reported on Oct, 5 by Barchart.com. If the $58.32 price target is reached, the company will be worth $769.69M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 727,393 shares traded hands or 401.38% up from the average. NanoString Technologies Inc (NASDAQ:NSTG) has risen 34.22% since March 2, 2016 and is uptrending. It has outperformed by 25.96% the S&P500.
Analysts await NanoString Technologies Inc (NASDAQ:NSTG) to report earnings on November, 7. They expect $-0.51 earnings per share, down 4.08% or $0.02 from last year’s $-0.49 per share. After $-0.55 actual earnings per share reported by NanoString Technologies Inc for the previous quarter, Wall Street now forecasts -7.27% EPS growth.
According to Zacks Investment Research, “NanoString Technologies, Inc. is engaged in the development, manufacture and sale of life science tools. It provides nCounter Analysis System which supports research and development of clinical applications from basic discovery to the development of future molecular diagnostic tests on a single platform. The company also offers nSolver Analysis software, gene expression panels, miRNA expression assay kits, cancer copy number variation panels, nCounter leukemia fusion gene expression assay kits and human karyotype panels, custom CodeSets and master kits that are ancillary reagents, cartridges, tips and reagent plates to setup and process samples in its instruments. It markets its systems and related consumables to researchers in academic, government and biopharmaceutical laboratories primarily in North America, Europe, the Middle East and the Asia Pacific. NanoString Technologies, Inc. is headquartered in Seattle, Washington.”
Insitutional Activity: The institutional sentiment increased to 2.52 in 2016 Q2. Its up 1.31, from 1.21 in 2016Q1. The ratio is positive, as 9 funds sold all NanoString Technologies Inc shares owned while 12 reduced positions. 15 funds bought stakes while 38 increased positions. They now own 16.55 million shares or 3.90% more from 15.93 million shares in 2016Q1.
Da Davidson & last reported 1,000 shares in the company. Dsc Advisors Ltd Partnership last reported 465,000 shares in the company. Penn Cap Mngmt Inc holds 141,905 shares or 0.1% of its portfolio. Moreover, Blackrock has 0% invested in NanoString Technologies Inc (NASDAQ:NSTG) for 759 shares. Tfs Ltd holds 26,384 shares or 0.06% of its portfolio. Millennium Mgmt Limited Liability has 0.01% invested in the company for 458,162 shares. Geode Management Limited Liability Company last reported 88,618 shares in the company. Legal General Grp Public Limited Company holds 0% of its portfolio in NanoString Technologies Inc (NASDAQ:NSTG) for 2,126 shares. Proshare Advsrs Ltd Co last reported 0% of its portfolio in the stock. Quantitative Systematic Strategies Ltd Liability Com accumulated 0.1% or 16,872 shares. The New York-based Tower Rech Ltd Liability Company (Trc) has invested 0% in NanoString Technologies Inc (NASDAQ:NSTG). Cadian Capital Mngmt Ltd Partnership holds 0.99% or 1.43M shares in its portfolio. Jacobs Levy Equity last reported 0% of its portfolio in the stock. Strs Ohio has 0% invested in the company for 31,900 shares. Blackrock Advsrs holds 6,974 shares or 0% of its portfolio.
Insider Transactions: Since August 12, 2016, the stock had 0 buys, and 6 insider sales for $8.52 million net activity. Shares for $669,812 were sold by WAITE CHARLES P JR. 3,961 shares were sold by BURNS WAYNE, worth $65,357 on Wednesday, September 7.
Another recent and important NanoString Technologies Inc (NASDAQ:NSTG) news was published by Quotes.Wsj.com which published an article titled: “News NanoString Technologies Inc.NSTG” on May 20, 2013.
NSTG Company Profile
NanoString Technologies, Inc., incorporated on June 20, 2003, develops, makes and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Firm operates in the segment of development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. The Company’s nCounter Analysis System is an automated, multi-application, digital detection and counting system, which directly profiles hundreds of molecules simultaneously using a barcoding technology. The Firm markets systems and related consumables to researchers in academic, government and biopharmaceutical laboratories for use in understanding fundamental biology and the molecular basis of diseases, such as cancer, and to clinical laboratories and medical centers for diagnostic use. The Company’s molecular diagnostic product Prosigna Breast Cancer Assay, or Prosigna, provides an assessment of a patient’s risk of recurrence for breast cancer. The Firm has an installed base of over 350 systems, which its clients have used to publish more than 1,000 peer-reviewed papers.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.